Review on circular RNAs and new insights into their roles in cancer

por Tang, Xiaozhu, Ren, Hongyan, Guo, Mengjie, Qian, Jinjun, Yang, Ye, Gu, Chunyan
Publicado 2021

Establishment and Verification of a Gene Signature for Diagnosing Type 2 Diabetics by WGCNA, LASSO Analysis, and In Vitro Experiments

por Shao, Huaming, Zhang, Yong, Liu, Yishuai, Yang, Yan, Tang, Xiaozhu, Li, Jiajia, Jia, Changxin
Publicado 2022

Elevated SFXN2 limits mitochondrial autophagy and increases iron-mediated energy production to promote multiple myeloma cell proliferation

por Chen, Ying, Qian, Jinjun, Ding, Pinggang, Wang, Wang, Li, Xinying, Tang, Xiaozhu, Tang, Chao, Yang, Ye, Gu, Chunyan
Publicado 2022

Correction for: CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation

por Lin, Zigen, Tang, Xiaozhu, Cao, Yuhao, Yang, Lijin, Jiang, Mingmei, Li, Xinying, Min, Jie, Chen, Bing, Yang, Ye, Gu, Chunyan
Publicado 2023

A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing

por Tang, Xiaozhu, Deng, Zhendong, Ding, Pinggang, Qiang, Wanting, Lu, Yue, Gao, Shengyao, Hu, Ye, Yang, Ye, Du, Juan, Gu, Chunyan
Publicado 2022

CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation

por Lin, Zigen, Tang, Xiaozhu, Cao, Yuhao, Yang, Lijin, Jiang, Mingmei, Li, Xinying, Min, Jie, Chen, Bing, Yang, Ye, Gu, Chunyan
Publicado 2022

BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability

por Tang, Xiaozhu, guo, Mengjie, Ding, Pinggang, Deng, Zhendong, Ke, Mengying, Yuan, Yuxia, Zhou, Yanyan, Lin, Zigen, Li, Muxi, Gu, Chunyan, Gu, Xiaosong, Yang, Ye
Publicado 2021

Splicing factor arginine/serine‐rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome‐based cellular communication

por Zhang, Yuanjiao, Yu, Xichao, Sun, Rongze, Min, Jie, Tang, Xiaozhu, Lin, Zigen, Xie, Siyuan, Li, Xinying, Lu, Shengfeng, Tian, Zhidan, Gu, Chunyan, Teng, Lesheng, Yang, Ye
Publicado 2022

HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA

por Jiang, Fengjie, Tang, Xiaozhu, Tang, Chao, Hua, Zhen, Ke, Mengying, Wang, Chen, Zhao, Jiamin, Gao, Shengyao, Jurczyszyn, Artur, Janz, Siegfried, Beksac, Meral, Zhan, Fenghuang, Gu, Chunyan, Yang, Ye
Publicado 2021

CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma

por Gu, Chunyan, Wang, Wang, Tang, Xiaozhu, Xu, Tingting, Zhang, Yanxin, Guo, Mengjie, Wei, Rongfang, Wang, Yajun, Jurczyszyn, Artur, Janz, Siegfried, Beksac, Meral, Zhan, Fenghuang, Seckinger, Anja, Hose, Dirk, Pan, Jingxuan, Yang, Ye
Publicado 2021

Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma

por Gu, Chunyan, Wang, Yajun, Zhang, Lulin, Qiao, Li, Sun, Shanliang, Shao, Miaomiao, Tang, Xiaozhu, Ding, Pinggang, Tang, Chao, Cao, Yuhao, Zhou, Yanyan, Guo, Mengjie, Wei, Rongfang, Li, Nianguang, Xiao, Yibei, Duan, Jinao, Yang, Ye
Publicado 2023

AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma

por Gu, Chunyan, Wang, Yajun, Zhang, Lulin, Qiao, Li, Sun, Shanliang, Shao, Miaomiao, Tang, Xiaozhu, Ding, Pinggang, Tang, Chao, Cao, Yuhao, Zhou, Yanyan, Guo, Mengjie, Wei, Rongfang, Li, Nianguang, Xiao, Yibei, Duan, Jinao, Yang, Ye
Publicado 2022